Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Marksans Pharma Limited ( (IN:MARKSANS) ) has issued an announcement.
Marksans Pharma Limited has announced an addendum to the notice of its 33rd Annual General Meeting, as published in the Business Standard and Lakshadeep newspapers. This announcement is part of the company’s compliance with regulatory requirements, reflecting its commitment to transparency and effective communication with stakeholders.
More about Marksans Pharma Limited
Marksans Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company primarily serves the global market with a variety of generic drugs and over-the-counter medications.
Average Trading Volume: 98,784
Technical Sentiment Signal: Buy
Current Market Cap: 103.3B INR
For an in-depth examination of MARKSANS stock, go to TipRanks’ Overview page.